Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

3 results about "Blood flow volume" patented technology

Blood flow. -the volume of blood that flows through any tissue in a given time period (in mL/min). -Total blood flow is cardiac output (CO), the volume of blood that circulates through systemic (or pulmonary) blood vessels each minute.

Normalized coronary artery microcirculation resistance index calculation method

PendingCN113693579ACatheterSensorsCoronary arteriesCoronary microcirculation
The invention provides a normalized coronary artery microcirculation resistance index calculation method. The method comprises the following steps: measuring far-end and near-end pressure values of an interested blood vessel in a maximum hyperemia state; reconstructing an three-dimensional model of the interested blood vessel based on an angiography image, and extracting a blood vessel far-end cross-sectional area at the same time; simulating and calculating blood flow resistance model parameters of the interested blood vessel; calculating the corresponding blood flow volume by combining the pressure values and the blood flow resistance model parameters; and calculating a normalized coronary artery microcirculation resistance index based on the pressure values, the blood flow volume and the blood vessel far-end cross-sectional area. According to the method, the normalized coronary artery microcirculation resistance index calculation method is provided on the basis of the angiography image and the invasive measurement pressure values, so that the unified microcirculation resistance calculation index can be established among blood vessels with different sizes at different parts of the coronary artery.
Owner:NORTHWESTERN POLYTECHNICAL UNIV

Application of Guanxinning composition in preparation of drugs for treating and/or preventing chronic fatigue syndrome

ActiveCN106943452AAntinoxious agentsPlant ingredientsSalvia miltiorrhizaDisease
The invention relates to the medicine field, and specifically relates to an application of a Guanxinning composition in the preparation of drugs for treating and / or preventing chronic fatigue syndrome. The Guanxinning composition is composed of red sage root and ligusticum wallichii according to a ratio of 1:1 and has the functions of promoting blood circulation to remove blood stasis, freeing the collateral vessels, and nourishing heart. At present, the Guanxinning composition is made into a Guanxinning injection. The Guanxinning water injection, which is developed in 1970s, has been on sale for more than thirty years, is a common traditional Chinese medicine injection for treating cardio-cerebrovascular diseases in clinic, and can improve the coronary circulation, prevent blood clotting, prominently increase the coronary blood-flow volume, improve myocardial blood supply, prevent and reduce the formation of thrombus, and reduce the range of embolism. The Guanxinning composition is mainly used to treat coronary heart disease and angina.
Owner:SHINEWAY PHARMA GRP LTD +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products